Is increased chronological age a contraindication to debulking surgery for elderly patients with advanced ovarian cancer?

被引:2
作者
Park, Soo Jin [1 ]
Mun, Jaehee [1 ]
Yim, Ga Won [2 ]
Lee, Maria [1 ]
Chung, Hyun Hoon [1 ]
Kim, Jae Weon [1 ]
Park, Noh Hyun [1 ]
Song, Yong Sang [1 ]
Kim, Hee Seung [1 ]
机构
[1] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
[2] Dongguk Univ, Dept Obstet & Gynecol, Coll Med, Goyang, South Korea
关键词
Aged; ovarian neoplasm; postoperative complications; prognosis; surgical procedure; CYTOREDUCTIVE SURGERY; CHEMOTHERAPY; MORBIDITY; COMORBIDITY; TOXICITY; OUTCOMES; RISK;
D O I
10.1080/01443615.2022.2112021
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
We collected data of elderly patients aged 65 years and older who underwent debulking surgery for advanced ovarian cancer in order to explore the impact of old age on surgical outcomes and complications. A total of 120 patients were classified as follows: group 1, 65-69 years (n = 58); group 2, 70-74 years (n = 38); group 3, 75-79 years (n = 17); group 4, >= 80 years (n = 7). There were no differences in most of the characteristics, surgical extent and outcomes, and postoperative complications between the four groups, whereas polypharmacy was more common (6 vs. 5-16; p=.02) and operation time was shorter (median, 194 vs. 285-330 min; p=.02) in group 4. Factors related to frailty rather than age, polypharmacy, preoperative albumin level, estimated blood loss and transfusion increased the risk of postoperative complications. Thus, the impact of old age on surgical extent, outcomes and postoperative complications may be minimal in elderly patients with advanced ovarian cancer. Impact Statement What is already known on this subject? Optimal debulking surgery is a significant factor in improving the prognosis of ovarian cancer but it is not easy to perform such radical surgery on elderly patients in fear of increasing surgical morbidity and mortality. Some studies suggest that underlying comorbidities may be a stronger contributing factor to increasing such risk rather than old age although there is not enough evidence yet. What do the results of this study add? Through this study, we could see that increased age is not the determining cause of increased morbidity and mortality in elderly patients who undergo optimal debulking surgery in ovarian cancer. There are other aspects describing a patient's health status that can predict prognosis better rather than age. What are the implications of these findings for clinical practice and/or further research? Old age need not be a contraindication when performing optimal debulking surgery in elderly patients with advanced ovarian cancer.
引用
收藏
页码:3254 / 3259
页数:6
相关论文
共 26 条
[1]   Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment [J].
Aletti, Giovanni D. ;
Eisenhauer, Eric L. ;
Santillan, Antonio ;
Axtell, Allison ;
Aletti, Giacomo ;
Holschneider, Christine ;
Chi, Dennis S. ;
Bristow, Robert E. ;
Cliby, William A. .
GYNECOLOGIC ONCOLOGY, 2011, 120 (01) :23-28
[2]   Feasibility of initial treatment in elderly patients with ovarian cancer in Japan: a retrospective study [J].
Bun, Seiko ;
Yunokawa, Mayu ;
Ebatas, Takahiro ;
Kato, Mayumi Kobayashi ;
Shimoi, Tatsunori ;
Kato, Tomoyasu ;
Tamura, Kenji .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (09) :1111-1118
[3]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[4]   Ovarian cancer in the elderly: Impact of surgery on morbidity and survival [J].
Chereau, E. ;
Ballester, M. ;
Selle, F. ;
Rouzier, R. ;
Darai, E. .
EJSO, 2011, 37 (06) :537-542
[5]   Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? [J].
Fanfani, F. ;
Fagotti, A. ;
Salerno, M. G. ;
Margariti, P. A. ;
Gagliardi, M. L. ;
Gallotta, V. ;
Vizzielli, G. ;
Panico, G. ;
Monterossi, G. ;
Scambia, G. .
EJSO, 2012, 38 (12) :1204-1210
[6]  
Freyer G, 2013, Am Soc Clin Oncol Educ Book, P227, DOI 10.1200/EdBook_AM.2013.33.227
[7]  
Glasheen WP, 2019, AM HEALTH DRUG BENEF, V12, P188
[8]   Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged ≥70 years with advanced ovarian cancer -: a study by the AGO OVAR Germany [J].
Hilpert, F. ;
du Bois, A. ;
Greimel, E. R. ;
Hedderich, J. ;
Krause, G. ;
Venhoff, L. ;
Loibl, S. ;
Pfisterer, J. .
ANNALS OF ONCOLOGY, 2007, 18 (02) :282-287
[9]   Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study [J].
Hurria, Arti ;
Togawa, Kayo ;
Mohile, Supriya G. ;
Owusu, Cynthia ;
Klepin, Heidi D. ;
Gross, Cary P. ;
Lichtman, Stuart M. ;
Gajra, Ajeet ;
Bhatia, Smita ;
Katheria, Vani ;
Klapper, Shira ;
Hansen, Kurt ;
Ramani, Rupal ;
Lachs, Mark ;
Wong, F. Lennie ;
Tew, William P. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (25) :3457-3465
[10]   Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients [J].
Jorgensen, Trine Lembrecht ;
Teiblum, Sandra ;
Paludan, Merete ;
Poulsen, Laurids Ostergaard ;
Jorgensen, Anni Young Stensgard ;
Bruun, Karin Herskind ;
Hallas, Jesper ;
Herrstedt, Jorn .
GYNECOLOGIC ONCOLOGY, 2012, 127 (02) :367-374